Entitled: “Investigators’ interests in and barriers to research studies on the health effects of cannabis and its constituents,” the notice states that the NIH acknowledges that 8 of their agencies are cooperating with the new efforts to determine what exactly is hindering research on the current Schedule 1 status of marijuana. They also want information on the limitations known about the products that are available for clinical trial use.